Ligand Pharmaceuticals reported $52.5M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acceleron Pharma XLRN:US $ 59.48M 9.66M
Agenus AGEN:US $ 168.75M 30.38M
Amgen AMGN:US $ 14585M 1716M
Anika Therapeutics ANIK:US $ 41.37M 5.61M
Arena Pharmaceuticals ARNA:US $ 64.84M 17.33M
Arrowhead Research ARWR:US $ 195.43M 28.25M
Baxter International BAX:US $ 3344M 157M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Clovis Oncology CLVS:US $ 173.88M 0.64M
Dicerna Pharmaceuticals DRNA:US $ 207.65M 25.5M
Eli Lilly And LLY:US $ 15093.2M 3379M
Enanta Pharmaceuticals ENTA:US $ 28.62M 2.01M
Endo International Ordinary Shares ENDP:US $ 1409.21M 13.72M
Flexion Therapeutics FLXN:US $ 39.93M 18.05M
Gilead Sciences GILD:US $ 10214M 509M
Glaxosmithkline GSK:US $ 21387M 1112M
GlaxoSmithKline GSK:LN 21387M 1112M
Harsco HSC:US $ 550.91M 32.18M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Immunogen IMGN:US $ 120.32M 14.03M
Insmed INSM:US $ 99.66M 18.26M
Intrexon XON:US $ 28.87M 3.63M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Lannett LCI:US $ 90.47M 6.66M
Ligand Pharmaceuticals LGND:US $ 52.5M 43.31M
Macrogenics MGNX:US $ 69.92M 16.88M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Rigel Pharmaceuticals RIGL:US $ 59.54M 7.52M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Spectrum Pharmaceuticals SPPI:US $ 56.7M 9.32M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
Veracyte VCYT:US $ 36.1M 3.4M